Hostname: page-component-848d4c4894-ttngx Total loading time: 0 Render date: 2024-05-28T07:47:43.958Z Has data issue: false hasContentIssue false

Drug Therapy and Memory Training Programs: A Double-Blind Randomized Trial of General Practice Patients With Age-Associated Memory Impairment

Published online by Cambridge University Press:  07 January 2005

Liliane Israel
Grenoble University Hospital, Grenoble, France
Michel Melac
Medical Research Division, UCB Pharma France, Nanterre, France
Daniel Milinkevitch
Medical Research Division, UCB Pharma France, Nanterre, France
Gérard Dubos
Geriatric Unit, Grenoble University Hospital, La Tronche, France


A double-blind randomized trial was performed involoving 162 patients with age-associated memory impairment (AAMI) selected and followed by their general practitioners. Two intervention methods—a drug and a cognitive therapy—were assessed in combination. Three randomized parallel groups of 54 patients each, aged 55 years and, over, were followed and treated for 3 months. After a placebo wash-out period of 10 days, one group received 2.4 g of piracetam, another group, 4.8g, and the third, a placebo. A total of 135 patients, 45 in each group, completed the study. Combined therapy was most effective in patients whose baseline performance on memory tests was lowest. The best results were observed with 4.8 g of piracetam, especially when training sessions began after 6 weeks of drug treatment. This result was confirmed by the global impression of the principal investigator.

Research and Reviews
© 1994 Springer Publishing Company

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)